Ibritumomab tiuxetan Y-90 INJ, single use yttrium-90 zevalin INJ, 3.2MG/2ML SDV
Ended Awarded Last action
- Contract number
- VA25514F0487
- Awardee
-
Spectrum Pharmaceuticals, Inc. UEI SC4WFM7J1EJ3
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $0
Award facts
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Irvine, CA 92618, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$22,324 | |
| Original award | $22,324 |
Quick answers
Who was awarded contract VA25514F0487?
VA25514F0487 was awarded to Spectrum Pharmaceuticals, Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on November 1, 2013.
How much is contract VA25514F0487 worth?
The government has obligated $0 on VA25514F0487.
Is contract VA25514F0487 an order under another contract?
Yes. VA25514F0487 is a delivery order under V797P5025B, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA25514F0487 competed?
The extent of competition for VA25514F0487 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award